BACKGROUND: Ataxia Telangiectasia (A-T) is a rare monogenetic neurodegenerative disease with pulmonary, nutritional, and dysphagic complications. Gastrostomy tube (GT) feedings are commonly recommended to manage these co-morbidities. In general, outcomes of GT placement in patients with progressive diseases that develop during childhood are not well characterized. The primary purposes of this study were to determine whether GT placement in patients with A-T would be tolerated and associated with caregiver satisfaction. METHODS: We completed a retrospective review of 175 patients who visited the A-T Children's Center at Johns Hopkins Hospital from 2001 through 2008, and identified 28 patients with A-T (19 males, 9 females) who underwent GT placement for non-palliative reasons. Information was obtained from medical records, interviews with primary health care providers, and 24 (83%) caregivers of patients with GT's who responded to survey requests. RESULTS: Twenty-five (89%) patients tolerated GT placement and were a median of 5.0 (0.4-12.6) years post GT placement at the time of this investigation. Three (11%) patients died within one month of GT placement. In comparison to patients who tolerated GT placement, patients with early mortality were older when GT's were placed (median 24.9 vs. 12.3 years, p = 0.006) and had developed a combination of dysphagia, nutritional, and respiratory problems. Caregivers of patients tolerating GT placement reported significant improvements in mealtime satisfaction and participation in daily activities. CONCLUSIONS: GT placement can be well tolerated and associated with easier mealtimes in patients with A-T when feeding tubes are placed at young ages. Patients with childhood onset of disorders with predictable progression of the disease process and impaired swallowing may benefit from early versus late placement of feeding tubes.
BACKGROUND:Ataxia Telangiectasia (A-T) is a rare monogenetic neurodegenerative disease with pulmonary, nutritional, and dysphagic complications. Gastrostomy tube (GT) feedings are commonly recommended to manage these co-morbidities. In general, outcomes of GT placement in patients with progressive diseases that develop during childhood are not well characterized. The primary purposes of this study were to determine whether GT placement in patients with A-T would be tolerated and associated with caregiver satisfaction. METHODS: We completed a retrospective review of 175 patients who visited the A-TChildren's Center at Johns Hopkins Hospital from 2001 through 2008, and identified 28 patients with A-T (19 males, 9 females) who underwent GT placement for non-palliative reasons. Information was obtained from medical records, interviews with primary health care providers, and 24 (83%) caregivers of patients with GT's who responded to survey requests. RESULTS: Twenty-five (89%) patients tolerated GT placement and were a median of 5.0 (0.4-12.6) years post GT placement at the time of this investigation. Three (11%) patients died within one month of GT placement. In comparison to patients who tolerated GT placement, patients with early mortality were older when GT's were placed (median 24.9 vs. 12.3 years, p = 0.006) and had developed a combination of dysphagia, nutritional, and respiratory problems. Caregivers of patients tolerating GT placement reported significant improvements in mealtime satisfaction and participation in daily activities. CONCLUSIONS:GT placement can be well tolerated and associated with easier mealtimes in patients with A-T when feeding tubes are placed at young ages. Patients with childhood onset of disorders with predictable progression of the disease process and impaired swallowing may benefit from early versus late placement of feeding tubes.
Authors: M A Lefton-Greif; T O Crawford; J A Winkelstein; G M Loughlin; C B Koerner; M Zahurak; H M Lederman Journal: J Pediatr Date: 2000-02 Impact factor: 4.406
Authors: K D Sanders; K Cox; R Cannon; D Blanchard; J Pitcher; P Papathakis; L Varella; R Maughan Journal: JPEN J Parenter Enteral Nutr Date: 1990 Jan-Feb Impact factor: 4.016
Authors: Mijke M M Verhagen; Marcel van Deuren; Michèl A A P Willemsen; Hans J Van der Hoeven; Yvonne F Heijdra; Jan-Bart Yntema; Corry M R Weemaes; Chris Neeleman Journal: Pediatr Pulmonol Date: 2009-01
Authors: T O Crawford; A S Mandir; M A Lefton-Greif; S N Goodman; B K Goodman; H Sengul; H M Lederman Journal: Neurology Date: 2000-04-11 Impact factor: 9.910
Authors: Mihai Puia-Dumitrescu; Daniel K Benjamin; P Brian Smith; Rachel G Greenberg; Nada Abuzaid; Winsome Andrews; Kris Chellani; Anjali Gupta; Douglas Price; Ciara Williams; William F Malcolm; Reese H Clark; Kanecia O Zimmerman Journal: JPEN J Parenter Enteral Nutr Date: 2019-03-25 Impact factor: 3.896
Authors: Cynthia Rothblum-Oviatt; Jennifer Wright; Maureen A Lefton-Greif; Sharon A McGrath-Morrow; Thomas O Crawford; Howard M Lederman Journal: Orphanet J Rare Dis Date: 2016-11-25 Impact factor: 4.123
Authors: Silmara Rondon-Melo; Isabel Junqueira de Almeida; Claudia Regina Furquim de Andrade; Fernanda Chiarion Sassi; Daniela Regina Molini-Avejonas Journal: Am J Case Rep Date: 2017-07-12
Authors: Svetlana O Sharapova; Olga E Pashchenko; Anastasiia V Bondarenko; Svetlana S Vakhlyarskaya; Tatjana Prokofjeva; Alina S Fedorova; Ihor Savchak; Yuliya Mareika; Timur T Valiev; Alexander Popa; Irina A Tuzankina; Elena V Vlasova; Inga S Sakovich; Ekaterina A Polyakova; Natalia V Rumiantseva; Irina V Naumchik; Svetlana A Kulyova; Svetlana N Aleshkevich; Elena I Golovataya; Nina V Minakovskaya; Mikhail V Belevtsev; Elena A Latysheva; Tatiana V Latysheva; Alexander G Beznoshchenko; Hayane Akopyan; Halyna Makukh; Olena Kozlova; Dzmitry S Varabyou; Mark Ballow; Mei-Sing Ong; Jolan E Walter; Irina V Kondratenko; Larysa V Kostyuchenko; Olga V Aleinikova Journal: Front Immunol Date: 2021-01-08 Impact factor: 7.561
Authors: Agata Pastorczak; Andishe Attarbaschi; Simon Bomken; Arndt Borkhardt; Jutte van der Werff Ten Bosch; Sarah Elitzur; Andrew R Gennery; Eva Hlavackova; Arpád Kerekes; Zdenka Křenová; Wojciech Mlynarski; Tomasz Szczepanski; Tessa Wassenberg; Jan Loeffen Journal: Cancers (Basel) Date: 2022-04-14 Impact factor: 6.575